Treatment of rheumatoid arthritis with ornidazole: a randomized, double-blind, placebo-controlled study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Rheumatology International

• Publication date

  2006-06-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00296-006-0145-0PMID 16770616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rheumatoid factor from periodontitis patients cross-reacts with epitopes on oral bacteria.

  2008cited by this paper
• Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis.

  2005cited by this paper
• Immunoglobulin G and A Antibody Responses to Bacteroides forsythus and Prevotella intermedia in Sera and Synovial Fluids of Arthritis Patients

  2003cited by this paper
• Autoantigenic posttranslational modifications of proteins: does it apply to rheumatoid arthritis?

  2002cited by this paper
• Self‐heat shock protein 60 induces tumour necrosis factor‐α in monocyte‐derived macrophage: possible role in chronic inflammatory periodontal disease

  2002cited by this paper
• Immunodominant Region of Actinobacillus actinomycetemcomitans 40-kilodalton Heat Shock Protein in Patients with Rheumatoid Arthritis

  2001cited by this paper
• Cytokines in periodontal disease: where to from here?

  2001cited by this paper
• Relationship between rheumatoid arthritis and periodontitis.

  2001cited by this paper
• Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine.

  2001cited by this paper
• The Antibacterial Effects of Ornidazole on Primary Molars with Infected Pulps

  2001cited by this paper
• Epitope mapping of heat shock protein 60 (GroEL) from Porphyromonas gingivalis.

  2000cited by this paper
• A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

  1999cited by this paper
• Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies)

  1999cited by this paper
• Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs.

  1998cited by this paper
• Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

  1998cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria.

  1997cited by this paper
• Bacterial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories.

  1995cited by this paper
• American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

  1995cited by this paper
• Heat Shock Proteins in the Human Periodontal Disease Process

  1995cited by this paper
• Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain.

  1994cited by this paper
• Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis.

  1994cited by this paper
• The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

  1993cited by this paper
• Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study.

  1993cited by this paper
• The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

  1993cited by this paper
• Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum.

  1993cited by this paper
• Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors.

  1993cited by this paper
• Rheumatoid factor (RF) distribution in periodontal disease

  1991cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis.

  1987cited by this paper
• A double‐blind, placebo‐controlled trial

  1986cited by this paper
• Sulfasalazine in rheumatoid arthritis. A double-blind, placebo-controlled trial.

  1986cited by this paper
• The association between rheumatoid arthritis and the HLA antigen DR4.

  1983cited by this paper
• Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire.

  1983cited by this paper
• The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

  1982cited by this paper
• Anti-anaerobic antibacterial agents.

  1982cited by this paper
• Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system.

  1981cited by this paper
• [Rheumatoid factor].

  1978cited by this paper
• [Etiology and pathogenesis of rheumatoid arthritis. I. ].

  1956cited by this paper
• Surgical treatment of pulmonary stenosis.

  1947cited by this paper

• A 5,6,11,12,17,18-Hexaazatrinaphthylene-Based Luminescent Metal-Organic Framework as Ornidazole Sensor with Extremely High Sensitivity

  2024cites this paper
• Distal Consequences of Oral Inflammation

  2019cites this paper
• The Microbiome in Rheumatic Diseases and Infection

  2018influential citation
• Design, optimization and characterizations of chitosan fortified calcium alginate microspheres for the controlled delivery of dual drugs

  2018cites this paper
• ASSAY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS QUANTITATIVE ESTIMATION OF DILOXANIDE FUROATE AND TINIDAZOLE IN TABLETS BY RP-HPLC

  2015cites this paper
• RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS QUANTITATIVE ESTIMATION OF DILOXANIDE FUROATE AND ORNIDAZOLE IN TABLETS

  2015cites this paper
• ASSAY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS QUANTITATIVE ESTIMATION OF DILOXANIDE FUROATE AND ORNIDAZOLE IN TABLETS BY RP-HPLC Original Article

  2015cites this paper
• RP-HPLC ASSAY METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF DILOXANIDE FUROATE AND ORNIDAZOLE IN TABLETS

  2015cites this paper
• A transient peak of infections during onset of rheumatoid arthritis: a 10-year prospective cohort study

  2014cites this paper
• Periodontitis and Etanercept Discontinuation Risk in Anti–Tumor Necrosis Factor–Naive Rheumatoid Arthritis Patients: A Nationwide Population-Based Cohort Study

  2013cites this paper
• Investigation of chiral inversion and pharmacokinetics of laevo‐ornidazole by high‐performance liquid chromatography

  2013cites this paper
• Pathogenesis of cardiovascular disease in the presence and absence of rheumatoid arthritis

  2012cites this paper
• Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

  2010cites this paper
• Sub-Chronic Toxicity Study of Fixed Dose Combination of Ofloxacin- Ornidazole in Mus Musculus Mice

  2009cites this paper
• Rheumatoid arthritis and periodontitis: biological links and the emergence of dual purpose therapies.

  2009cites this paper
• Levofloxacin Treatment in Patients with Rheumatoid Arthritis Receiving Methotrexate

  2007cites this paper